Skip to content

A multicenter, prospective and controlled study for nutritional intervention in patients with severe hepatitis B (liver failure)

A multicenter, prospective and controlled study for nutritional intervention in patients with severe hepatitis B (liver failure) (one topic of the research and application of new technology, new equipment and new scheme of the diagnosis and treatment of severe hepatitis B (liver feilure))

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025809
Enrollment
Unknown
Registered
2019-09-09
Start date
2019-09-09
Completion date
Unknown
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sever hepatitis B (liver failure)

Interventions

Nutrition intervention group:nutritional intervention
Control:Nutrition intake according to one's own wishes

Sponsors

The First Affiliated Hospital of Medical College, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) The patient agrees to participate in the study and sign the informed consent. 2) Unlimited sex, aged 18-65 years; 3) HBsAg positive lasted for more than 6 months and HBV-DNA positive (higher than 200 IU/ml); 4) Extreme fatigue and severe gastrointestinal symptoms such as anorexia, abdominal distension, nausea and vomiting. 5) Progressive deepening of jaundice in a short period of time (serum total bilirubin is 10 times higher than the upper limit of normal value or increases daily by more than 17.1 umol/L); 6) The tendency of bleeding was obvious, PTA was less than 40%, and other causes were excluded.

Exclusion criteria

Exclusion criteria: 1) Acute fatty liver of pregnancy; 2) Drug-induced liver injury; 3) Alcoholic liver disease (drinking more than 20 g per day for women, 40 g for men and more than 5 years); 4) Autoimmune liver disease; 5) Congenital metabolic liver diseases, such as Wilson's disease, hemochromatosis, etc.; 6) Severe hepatitis caused by hepatitis B recurrence after transplantation; 7) Patients with other viral infections were positive for anti-HAV IgM, anti-HCV, anti-HEV IgM, anti-HEV-IgG, anti-HDV-IgM and anti-HIV antibodies. 8) Complicated with serious underlying diseases, including uncontrolled clinically significant heart, lung, kidney, digestion, nerve, mental disorders, immune diseases, metabolic diseases, malignant tumors, etc.

Design outcomes

Primary

MeasureTime frame
Body Composition Analysis;liver function;Daily total energy intake;????????;

Countries

China

Contacts

Public ContactHuang Jianrong

The First Affiliated Hospital of Medical College, Zhejiang University

hzhuangchina@sina.com+86 0571-87236743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026